Conus Venoms: A Rich Source of Novel Ion Channel-Targeted Peptides

Physiological Reviews

Volumn 84, Issue 1, 2004, Pages 41-68

  Terlau, Heinrich ^a   Olivera, Baldomero M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CONOTOXIN; CALCIUM CHANNEL; CHOLINERGIC RECEPTOR; CONOTOXIN; ION CHANNEL; NICOTINIC RECEPTOR; OMEGA CONOTOXIN; POTASSIUM CHANNEL; SODIUM CHANNEL; UNCLASSIFIED DRUG; VENOM;

BINDING SITE; EVOLUTION; KNOCKOUT GENE; LIGAND BINDING; MOLECULAR GENETICS; MUTANT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SNAIL;

ANIMALS; CONOTOXINS; HUMANS; ION CHANNEL GATING; ION CHANNELS; MUSCLE, SKELETAL; PEPTIDES; SNAILS;

EID: 0347989461     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00020.2003     Document Type: Review

References (196)

1. Adams DJ, Smith AB, Schroeder CI, Yasuda T, and Lewis RJ. ω-Conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals. J Biol Chem. In press.
2. Adams ME and Olivera BM. Neurotoxins: overview of an emerging research technology. Trends Neurosci 17: 151-155, 1994.
3. Allen RS, Cui C, and Heinemann SF. Gene targeted knockout of the mouse β3 neuronal nicotinic acetylcholine receptor subunit. Soc Neurosci Abstr 530: 9, 1998.
4. Arneric SP and Holladay MW. Agonists and antagonist of nicotinic acetylcholine receptors. In: Handbook of Experimental Pharmacology. Neuronal Nicotinic Receptors, edited by Clementi F, Fornasari D, and Gotti C. Berlin: Springer-Verlag, 2000, vol. 144, chapt. 16, p. 419-443.
5. Avdonin V, Nolan B, Sabatier JM, De Waard M, and Hoshi T. Mechanisms of maurotoxin action on Shaker potassium channel. Biophys J 79: 776-787, 2000.
6. Azam L, Dowell C, and McIntosh JM. Characterization of nicotine-mediated dopamine release from striatal synaptosomes using a novel α-conotoxin. Soc Neurosci Abstr program no. 2429, 2002.
7. Baer M, Best M, and Reuter H. Voltage-dependent action of tetrodotoxin in mammalian cardiac muscle. Nature 263: 344-345, 1976.
8. Bandyopadhyay PK, Colledge CJ, Walker CS, Zhou LM, Hillyard DR, and Olivera BM. Conantokin-G precursor and its role in γ-carboxylation by a vitamin K-dependent carboxylase from a Conus snail. J Biol Chem 273: 5447-5450, 1998.
9. Bandyopadhyay PK, Garrett JE, Shetty RP, Keate T, Walker CS, and Olivera BM. γ-Glutamyl carboxylation: an extracellular post-translational modification that antedates the divergence of molluscs, arthropods and chordates. Proc Natl Acad Sci USA 99: 1264-1269, 2002.
10. Becker S, Prusak-Sochaczewski E, Zamponi G, Beck-Sickinger AG, Gordon RD, and French RJ. Action of derivatives of μ-conotoxin GIIIA on sodium channels. Single amino acid substitutions in the toxin separately affect association and dissociation rates. Biochemistry 31: 8229-8238, 1992.
11. +. Biophys J 82: 1140, 2002.
12. Bren N and Sine SM. Hydrophobic pairwise interactions stabilize α-conotoxin MI in the muscle acetylcholine receptor binding site. J Biol Chem 275: 12692-12700, 2000.
13. Bulaj G, Delacruz R, Azimi-Zonooz A, West P, Watkins M, Yoshikami D, and Olivera BM. δ-Conotoxin structure/function through a cladistic analysis. Biochemistry 40: 13201-13208, 2001.
14. Carmeliet E. Voltage-dependent block by tetrodotoxin of the sodium channel in rabbit cardiac purkinje fibers. Biophys J 51: 109-114, 1987.
15. Cartier GE. A-Conotoxin MII: A New Tool for the Study of Neuronal Nicotinic Acetylcholine Receptors (PhD thesis). Salt Lake City, UT: Univ. of Utah, 2002.
16. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, and McIntosh JM. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271: 7522-7528, 1996.
17. Catterall WA. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 72 Suppl: S15-S48, 1992.
18. Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26: 13-25, 2000.
19. Chahine M, Sirois J, Marcotte P, Chen L, and Kallen RG. Extrapore residues of the S5-S6 loop of domain 2 of the voltage-gated skeletal muscle sodium channel (rSkM1) contribute to the μ-conotoxin GIIIA binding site. Biophys J 75: 236-246, 1998.
20. Champtiaux N, Han ZY, Bessis A, Rossi FM, Zoli M, Marubio L, McIntosh JM, and Changeux JP. Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analysed with mutant mice. J Neurosci 22: 1208-1217, 2002.
21. Chen LQ, Chahine M, Kallen RG, Barchi RL, and Horn R. Chimeric study of sodium channels for rat skeletal and cardiac muscle. FEBS Lett 309: 253-257, 1992.
22. Chen Z, Blandl T, Prorok M, Warder SE, Li L, Zhu Y, Pedersen LG, Ni F, and Castellino FJ. Conformational changes in conantokin-G induced upon binding of calcium and magnesium as revealed by NMR structural analysis. J Biol Chem 273: 16248-16258, 1998.
23. Cohen CJ, Bean BP, Colatsky TJ, and Tsien RW. Tetrodotoxin block of sodium channels in rabbit Purkinje fibers. Interactions between toxin binding and channel gating. J Gen Physiol 78: 383-411, 1981.
24. Conti F, Gheri A, Pusch M, and Moran O. Use dependence of tetrodotoxin block of sodium channels: a revival of the trapped-ion mechanism. Biophys J 71: 1295-1312, 1996.
25. Conticello SG, Gilad Y, Avidan N, Ben-Asher E, Levy Z, and Fainzilber M. Mechanisms for evolving hypervariability: the case of conopeptides. Mol Biol Evol 18: 120-131, 2001.
26. Cox JC. Poisonous effects of the bite inflicted by Conus geographicus. Linn Proc Linnean Soc 9: 944-946, 1884.
27. Craig AG, Bandyopadhyay P, and Olivera BM. Post-translationally modified peptides from Conus venoms. Eur J Biochem 264: 271-275, 1999.
28. Craig AG, Jimenez EC, Dykert J, Nielsen DB, Gulyas J, Abogadie FC, Porter J, Rivier JE, Cruz LJ, Olivera BM, and McIntosh JM. A novel post-translational modification involving bromination of tryptophan: identification of the residue, L,6-bromotryptophan, in peptides from Conus imperialis and Conus radiatus venom. J Biol Chem 272: 4689-4698, 1997.
29. Craig AG, Norberg T, Griffin D, Hoeger C, Akhtar M, Schmidt K, Low W, Dykert J, Richelson E, Navarro V, Macella J, Watkins M, Hillyard D, Imperial J, Cruz LJ, and Olivera BM. Contulakin-G, an O-glycosylated invertebrate neurotensin. J Biol Chem 274: 13752-13759, 1999.
30. Craig AG, Zafaralla G, Cruz LJ, Santos AD, Hillyard DR, Dykert J, Rivier JE, Gray WR, Imperial J, Delacruz RG, Sporning A, Terlau H, West PJ, Yoshikami D, and Olivera BM. An O-glycosylated neuroexcitatory Conus peptide. Biochemistry 37: 16019-16025, 1998.
31. Cruz LJ, De Santos V, Zafaralla GC, Ramilo CA, Zeikus R, Gray WR, and Olivera BM. Invertebrate vasopressin/oxytocin homologs. Characterization of peptides from Conus geographus and Conus striatus venoms. J Biol Chem 262: 15821-15824, 1987.
32. Cruz LJ, Gray WR, and Olivera BM. Purification and properties of a myotoxin from Conus geographus venom. Arch Biochem Biophys 190: 539-548, 1978.
33. Cruz LJ, Gray WR, Olivera BM, Zeikus RD, Kerr L, Yoshikami D, and Moczydlowski E. Conus geographus toxins that discriminate between neuronal and muscle sodium channels. J Biol Chem 260: 9280-9288, 1985.
34. Cruz LJ, Kupryszewski G, Lecheminant GW, Gray WR, Olivera BM, and Rivier J. μ-Conotoxin GIIIA, a peptide ligand for muscle sodium channels: chemical synthesis, radiolabeling and receptor characterization. Biochemistry 28: 3437-3442, 1989.
35. Cruz LJ and White J. Clinical toxicology of Conus snail stings. In: Clinical Toxicology of Animal Venoms, edited by Meier J and White J. Boca Raton, FL: CRC, 1995.
36. Czerwiec E, Begley GS, Bronstein M, Stenflo J, Taylor KL, Furie BC, and Furie B. Expression and characterization of recombinant vitamin K-dependent γ-glutamyl carboxylase from an invertebrate, Conus textile. Eur J Biochem 269: 6162-6172, 2002.
37. Dauplais M, Lecoq A, Song J, Cotton J, Jamin N, Gilquin B, Roumestand C, Vita C, De Medeiros C, Rowan EG, Harvey AL, and Ménez A. On the convergent evolution of animal toxins. Conservation of a diad of functional residues in potassium channel-blocking toxins with unrelated structures. J Biol Chem 272: 4802-4809, 1997.
38. Donevan SD and McCabe RT. Conantokin-G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. Mol Pharmacol 58: 614-623, 2000.
39. + conduction and selectivity. Science 280: 69-77, 1998.
40. Duda TF Jr and Palumbi SR. Molecular genetics of ecological diversification: duplication and rapid evolution of toxin genes of the venomous gastropod Conus. Proc Natl Acad Sci USA 96: 6820-6823, 1999.
41. + channel predict a clockwise arrangement of the domains. J Gen Physiol 116: 679-689, 2000.
42. + channel mutant: possible localization of a binding site at the outer vestibule. Biophys J 69: 1657-1665, 1995.
43. 2+ channels in mammalian central neurons. Trends Neurosci 18: 89-98, 1995.
44. Eickhorn R, Weirich J, Hornung D, and Antoni H. Use dependence of sodium current inhibition by tetrodotoxin in rat cardiac muscle: influence of channel state. Pflügers Arch 416: 398-405, 1990.
45. Ellison M, McIntosh JM, and Olivera BM. α-Conotoxins ImI and ImII: similar α7 nicotinic receptor antagonists act at different sites. J Biol Chem 278: 757-764, 2003.
46. Ellison MA. Novel Natural and Combinatorial α4,3 Conotoxins as Inhibitors of the α7 Nicotinic Acetylcholine Receptor (PhD thesis). Salt Lake City, UT: Univ. of Utah, 2003.
47. Endean R, Parrish G, and Gyr P. Pharmacology of the venom of Conus geographus. Toxicon 12: 131-138, 1974.
48. England LJ, Imperial J, Jacobsen R, Craig AG, Gulyas J, Akhtar M, Rivier J, Julius D, and Olivera BM. Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails. Science 281: 575-578, 1998.
49. Espiritu DJD, Watkins M, Dia-Monje V, Cartier GE, Cruz LJ, and Olivera BM. Venomous cone snails: molecular phylogeny and the generation of toxin diversity. Toxicon 39: 1899-1916, 2001.
50. Fainzilber M, Hasson A, Oren R, Burlingame AL, Gordon D, Spira ME, and Zlotkin E. New mollusc-specific α-conotoxins block Aplysia neuronal acetylcholine receptors. Biochemistry 33: 9523-9529, 1994.
51. Fainzilber M, Lodder JC, Van Der Schors RC, Li KW, Yu Z, Burlingame AL, Geraerts WP, and Kits KS. A novel hydrophobic ω-conotoxin blocks molluscan dihydropyridine-sensitive calcium channels. Biochemistry 35: 8748-8752, 1996.
52. Fainzilber M, Nakamura T, Gaathon A, Lodder JC, Kits KS, Burlingame AL, and Zlotkin E. A new cysteine framework in sodium channel blocking conotoxins. Biochemistry 34: 8649-8656, 1995.
53. Fainzilber M, Nakamura T, Lodder JC, Zlotkin E, Kits KS, and Burlingame AL. γ-Conotoxin PnVIIA, a γ-carboxyglutamate-containing peptide agonist of neuronal pacemaker cation currents. Biochemistry 37: 1470-1477, 1998.
54. Fan CX, Chen XK, Zhang C, Wang LX, Duan KL, He LL, Cao Y, Liu SY, Zhong MN, Ulens C, Tytgat J, Chen JS, Chi CW, and Zhou Z. A novel conotoxin from Conus betulinus, K-BtX, unique in cysteine pattern and in function is a specific BK channel modulator. J Biol Chem M210200200, 2003.
55. + channels. J Biol Chem 278: 2177-2183, 2002.
56. French RJ, Prusak-Sochaczewski E, Zamponi GW, Becker S, Kularatna AS, and Horn R. Interactions between a pore-blocking peptide and the voltage-sensor of the sodium channel: an electrostatic approach to channel geometry. Neuron 16: 407-413, 1996.
57. Goldin A.L. Resurgence of sodium channel research. Annu Rev Physiol 63: 871-894, 2001.
58. Goldin AL, Barchi RL, Caldwell JH, Hofmann F, Howe Hunter JC, Kallen RG, Mandel G Jr, Meisler MH, Berwald Netter Y, Noda M, Tamkun MM, Waxman SG, Wood JN, and Catterall WA. Nomenclature of voltage-gated sodium channels. Neuron 28: 365-368, 2000.
59. Gray WR, Luque A, Olivera BM, Barrett J, and Cruz LJ. Peptide toxins from Conus geographus venom. J Biol Chem 256: 4734-4740, 1981.
60. Gray WR, Olivera BM, and Cruz LJ. Peptide toxins from venomous Conus snails. Annu Rev Biochem 57: 665-700, 1988.
61. Haack JA〈 Rivier J, Parks TN, Mena EE, Cruz LJ, and Olivera BM. Conantokin T: a γ-carboxyglutamate-containing peptide with N-methyl-D-aspartate antagonist activity. J Biol Chem 265: 6025-6029, 1990.
62. Hammerland LG, Olivera BM, and Yoshikami D. Conantokin-G selectively inhibits NMDA-induced currents in Xenopus oocytes injected with mouse brain mRNA. Eur J Pharmacol 226: 239-244, 1992.
63. Han KH, Hwang KJ, Kim SM, Kim SK, Gray WR, Olivera BM, Rivier J, and Shon K. NMR structure determination of a novel conotoxin [Pro7,13]α A-conotoxin PIVA. Biochemistry 36: 1669-1677, 1997.
64. Hasson A, Shon KJ, Olivera BM, and Spira ME. Alterations of voltage-activated sodium current by a novel conotoxin from the venom of Conus gloriamaris. J Neurophys 73: 1295-1301, 1995.
65. + channel pore through mutant cycles with a peptide inhibitor. Science 268: 307-310, 1995.
66. Hilber K, Sandtaer W, Kudlacek O, Glaaser IW, Weisz E, Kyle JW, French RJ, Fozzard HA, Dudley SC, and Todt H. The selectivity filter of the voltage-gated sodium channel is involved in channel activation. J Biol Chem 276: 27831-27839, 2001.
67. Hille B. Ion Channels of Excitable Membranes (3rd ed.). Sunderland, MA: Sinauer, 2001.
68. 2+ channels. Neuron 9: 69-77, 1992.
69. Hillyard DR, Olivera BM, Woodward S, Gray WR, Corpuz GP, Ramilo CA, and Cruz LJ. A molluscivorous Conus toxin: conserved frameworks in conotoxins. Biochemistry 28: 358-361, 1989.
70. Hodgkin AL and Huxley AF. Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo. J Physiol 116: 449-472, 1952.
71. Hodgkin AL, Huxley AF, and Katz B. Measurements od current-voltage relations in the membranes of the giant axon of Loligo. J Physiol 116: 424-448, 1952.
72. Hooper D, Lirazan MB, Schoenfeld R, Cook B, Cruz LJ, Olivera BM, and Bandyopadhyay P. Post-translational modification: a two-dimensional strategy for molecular diversity of Conus peptides. In: Peptides for the New Millennium: Proceedings of the Sixteenth American Peptide Symposium, edited by Fields GB, Tam JP, and Barany G. Dordrecht, The Netherlands: Kluwer Academic, 2000.
73. Hopkins C, Grilley M, Miller C, Shon K, Cruz LJ, Gray WR, Dykert J, Rivier J, Yoshikami D, and Olivera BM. A new family of Conus peptides targeted to the nicotinic acetylcholine receptor. J Biol Chem 270: 22361-22367, 1995.
74. Hui K, Lipkind G, Fozzard HA, and French RJ. Electrostatic and steric contributions to block of the skeletal muscle sodium channel by μ-conotoxin. J Gen Physiol 119: 45-54, 2002.
75. Jacobsen R, Jimenez EC, Grilley M, Watkins M, Hillyard D, Cruz LJ, and Olivera BM. The contryphans, a D-tryptophan-containing family of Conus peptides: interconversion between conformers. J Peptide Res 51: 173-179, 1998.
76. Jacobsen R, Yoshikami D, Ellison M, Martinez J, Gray WR, Cartier GE, Shon KJ, Groebe DR, Abramson SN, Olivera BM, and McIntosh JM. Differential targeting of nicotinic acetylcholine receptors by novel αA-conotoxins. J Biol Chem 272: 22531-22537, 1997.
77. Jacobsen RB, Delacruz RG, Grose JH, McIntosh JM, Yoshikami D, and Olivera BM. Critical residues influence the affinity and selectivity of α-conotoxin MI for nicotinic acetylcholine receptors. Biochemistry 38: 13310-13315, 1999.
78. + channel. J Biol Chem 275: 24639-24644, 2000.
79. Jan LY and Jan YN. Cloned potassium channels from eukaryotes and prokaryotes. Annu Rev Neurosci 20: 91-123, 1997.
80. + channel. Nature 423: 33-41, 2003.
81. + channel. Nature 423: 42-48, 2003.
82. Jimenez EE, Craig AG, Watkins M, Hillyard DR, Gray WR, Gulyas J, Rivier JE, Cruz LJ, and Olivera BM. Bromocontryphan: post-translational bromination of tryptophan. Biochemistry 36: 989-994, 1997.
83. Jimenez EC, Donevan SD, Walker C, Zhou LM, Nielsen J, Cruz LJ, Armstrong H, White HS, and Olivera BM. Conantokin-L, a new NMDA receptor antagonist: determinants for anti-convulsant potency. Epilepsy Res 51: 73-80, 2002.
84. Jimenez EE, Olivera BM, Gray WR, and Cruz LJ. Contryphan is a D-tryptophan-containing Conus peptide. J Biol Chem 281: 28002-28005, 1996.
85. Jimenez EC, Shetty RP, Lirazan M, Rivier J, Walker C, Abogadie FC, Yoshikami D, Cruz LJ, and Olivera BM. Novel excitatory Conus peptides define a new conotoxin superfamily. J Neurochem 85: 610-621, 2003.
86. Jones RM and Bulaj G. Conotoxins: new vistas for peptide therapeutics. Curr Pharmaceutical Design 6: 1249-1255, 2000.
87. Kandel ER, Schwartz JH, and Jessel TM. Principles of Neural Science (4th ed.). New York: McGraw-Hill, 2000.
88. Kauferstein S, Huys I, Lamthanh H, Stöcklin R, Sotto F, Menez A, Tytgat J, and Mebs D. A novel conotoxin inhibiting vertebrate voltage-sensitive potassium channes. Toxicon 42: 43-52, 2003.
89. Kehoe J and McIntosh JM. Two distinct nicotinic receptors, one pharmacologically similar to the vertebrate α7-containing receptor, mediate Cl currents in Aplysia neurons. J Neurosci 18: 8198-8213, 1998.
90. 13 is essential for the activity of ω-conotoxin GVIA, a peptide toxin for N-type calcium channel. J Biol Chem 273: 23876-23878, 1994.
91. Kim M, Baro DJ, Lanning CC, Doshi M, Farnham J, Moskowitz HS, Peck JH, Olivera BM, and Harris-Warrick RM. Alternative splicing in the pore-forming region of Shaker potassium channels. J Neurosci 17: 8213-8224, 1997.
92. Klein RC, Galdzicki Z, and Castellino FJ. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons. Neuropharmacology 38: 1819-1829, 1999.
93. Klein RC, Prorok M, Galdzicki Z, and Castellino FJ. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. J Biol Chem 276: 26860-26867, 2001.
94. + channels. Eur J Physiol 441: R142, 2001.
95. Kohn AJ. The ecology of Conus in Hawaii. Ecol Monogr 29: 47-90, 1959.
96. Kohn AJ. Evolutionary ecology of Conus on Indo-Pacific coral reefs. Proc Fifth Int Coral Reef Cong 4: 139-144, 1985.
97. Kohn AJ, Omori M, Yamakawa H, and Koike Y. Maximal species richness in Conus: diversity, diet and habitat on reefs of northeast Papua New Guinea. Coral Reefs 20: 25-38, 2001.
98. Kohn AJ, Saunders PR, and Wiener S. Preliminary studies on the venom of the marine snail Conus. Ann NY Acad Sci 90: 706-725, 1960.
99. Kulak JM, Nguyen TA, Olivera BM, and McIntosh JM. α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J Neurosci 17: 5263-5270, 1997.
100. Laube B, Hirai H, Sturgess M, Betz H, and Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamte binding site on the NR2B subunit. Neuron 18: 493-503, 1997.
101. +-dependent mechanism. Eur J Neurosci 11: 3134-3142, 1999.
102. Lew MJ, Flinn JP, Pallaghy PK, Murphy R, Whorlow SL, Wright CE, Norton RS, and Angus JA. Structure-function relationships of ω-conotoxin GVIA. Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogs. J Biol Chem 272: 12014-12023, 1997.
103. Lewis RJ, Nielsen KJ, Craik DJ, Loughnan ML, Adams DA, Sharpe IA, Luchian T, Adams DJ, Bond T, Thomas L, Jones A, Matheson JL, Drinkwater R, Andrews PR, and Alewood PF. Novel ω-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem 275: 35335-35344, 2000.
104. Lin CH, Chen CS, Hsu Ks, King DS, and Lyu PC. Role of modified glutamic in the helical structure of conantokin-T. FEBS Lett 407: 243-248, 1997.
105. Lirazan M, Jimenez EC, Craig AG, Olivera BM, and Cruz LJ. Conophysin-R, a Conus radiatus venom peptide belonging to the neurophysin family. Toxicon 40: 901-908, 2002.
106. Lirazan MB, Hooper D, Corpuz GP, Ramilo CA, Bandyopadhyay P, Cruz LJ, and Olivera BM. The spasmodic peptide defines a new conotoxin superfamily. Biochemistry 39: 1583-1588, 2000.
107. Livett B, Khalil Z, Gayler K, and Down J. Alpha conotoxin peptides with analgesic properties. Proceedings of the World Intellectual Property Organization, International Bureau, 2002, WO 02/079236 A1.
108. Lönnendonker U. Use-dependent block of sodium channels in frog myelinated nerve by tetrodotoxin and saxitoxin at negative holding potentials. Biochim Biophys Acta 985: 153-160, 1989.
109. Loughnan M, Bond T, Atkins A, Cuevas J, Adams DJ, Broxton NM, Livett BG, Down JG Jones A, Alewood PF, and Lewis RJ. α-Conotoxin EpI, a novel sulfated peptide from Conus episcopatus that selectively targets neuronal nicotinic acetylcholine receptors. J Biol Chem 273: 15667-15674, 1998.
110. Luo S, Kulak JM, Cartier GE, Jacobsen RB, Yoshikami D, Olivera BM, and McIntosh JM. α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J Neurosci 18: 8571-8579, 1998.
111. Luo S, Nguyen TA, Cartier GE, Olivera BM, Yoshikami D, and McIntosh JM. Single-residue alteration in α-conotoxin PnIA switches its nAChR subtype selectivity. Biochemistry 38: 14542-14548, 1999.
112. Macgillivray J. Zoological notes from Aneiteum, New Hebrides. Zoologist 19: 7136-7138, 1860.
113. Maillo M, Aguilar MB, Lopez-Vera E, Craig AG, Bulaj G, Olivera BM, and Heimer De La Cortera EP. Conorfamide, a Conus venom peptide belonging to the RFamide family of neuropeptides. Toxicon 40: 401-417, 2002.
114. Martinez JS, Olivera BM, Gray WR, Craig AG, Groebe DR, Abramson SN, and McIntosh JM. α-Conotoxin EI, a new nicotinic acetylcholine receptor-targeted peptide. Biochemistry 34: 14519-14526, 1995.
115. + channels. Biochem Biophys Res Commun 303: 238-246, 2003.
116. Massilia GR, Schininà ME, Ascenzi P, and Polticelli F. Contryphan-Vn: a novel peptide from the venom of the Mediterranean snail Conus ventricosus. Biochem Biophys Res Commun 288: 908-913, 2001.
117. McIntosh JM. Toxin antagonists of the neuronal nicotinic acetylcholine receptor In: Handbook of Experimental Pharmacology. Neuronal Nicotinic Receptors, edited by Clementi F, Fornasari D, and Gotti C. Berlin: Springer-Verlag, 2000, vol. 144, chapt. 17, p. 455-476.
118. McIntosh JM, Corpuz GP, Layer RT, Garrett JE, Wagstaff JD, Bulaj G, Vyazovkina A, Yoshikami D, Cruz LJ, and Olivera BM. Isolation and characterization of a novel Conus peptide with apparent antinociceptive activity. J Biol Chem 275: 32391-32397, 2000.
119. McIntosh JM, Cruz LJ, Hunkapiller MW, Gray WR, and Olivera BM. Isolation and structure of a peptide toxin from the marine snail Conus magus. Arch Biochem Biophys 218: 329-334, 1982.
120. 2 isolated from the venom of the marine snail Conus magus. J Biol Chem 270: 3518-3526, 1995.
121. McIntosh JM, Hasson A, Spira ME, Gray WR, Li W, Marsh M, Hillyard DR, and Olivera BM. A new family of conotoxins that blocks voltage-gated sodium channels. J Biol Chem 270: 16796-16802, 1995.
122. McIntosh JM, Olivera BM, and Cruz LJ. Conus peptides as probes for ion channels. Methods Enzymol 294: 605-624, 1999.
123. McIntosh JM, Olivera BM, Cruz LJ, and Gray WR. γ-Carboxyglutamate in a neuroactive toxin. J Biol Chem 259: 14343-14346, 1984.
124. McIntosh JM, Santos AD, and Olivera BM. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu Rev Biochem 68: 59-88, 1999.
125. McIntosh JM, Yoshikami D, Mahe E, Nielsen DB, Rivier JE, Gray WR, and Olivera BM. A nicotinic acetylcholine receptor ligand of unique specificity, α-conotoxin ImI. J Biol Chem 269: 16733-16739, 1994.
126. Mena EE, Gullak MF, Pagnozzi MJ, Richter KE, Rivier J, Cruz LJ, and Oivera BM. Conantokin-G: a novel peptide antagonist to the N-methyl-D-aspartate acid (NMDA) receptor. Neurosci Lett 118: 241-244, 1990.
127. Miljanich GP. Venom peptides as human pharmaceuticals. Science Med 6-15, 1997.
128. Mitchell SS, Shon K, Foster MIP, Davis DR, Olivera BM, and Ireland CM. Three-dimensional solution structure of conotoxin ψ-PIIIE, an acetylcholine gated ion channel antagonist. Biochemistry 37: 1215-1220, 1998.
129. 3H]saxitoxin and μ-conotoxins. Proc Natl Acad Sci USA 83: 5321-5325, 1986.
130. + selectivity filter. Nature 414: 37-42, 2001.
131. 2+ entry into neurons. J Toxicol Toxin Rev 9: 179-202, 1990.
132. Nadasdi L, Yamashiro D, Chung D, Tarczy-Hornoch K, Adriaenssens P, and Ramachandran J. Structure-activity analysis of a Conus peptide blocker of N-type neuronal calcium channel. Biochemistry 34: 8076-8081, 1995,
133. Nakamura H, Kobayashi J, Ohizumi Y, and Hirata Y. The occurrence of arachidonic acid in the venom duct of the marine snail Conus textile. Experientia 39: 897, 1982.
134. 13 on the structure-activity relationships of ω-conotoxins from Conus magus. Biochemistry 38: 6741-6751, 1999.
135. Nielsen KJ, Watson M, Adams DJ, Hammarström AK, Gage PW, Hill JM, Craik DJ, Thomas L, Adams D, Alewood PF, and Lewis RJ. Solution structure of μ-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels. J Biol Chem 277: 27247-27255, 2002.
136. + channels. Jpn J Pharmacol 88: 365-377, 2002.
137. Olivera BM. Conus venom peptides, receptor and ion channel targets and drug design: 50 million years of neuropharmacology (EE Just Lecture, 1996). Mol Biol Cell 8: 2101-2109, 1997.
138. Olivera BM. ω-Conotoxin MVIIA: from marine snail venom to analgesic drug. In: Drugs from the Sea, edited by Fusetani N. Basel: Karger, 2000.
139. Olivera BM. Conus venom peptides: reflections from the biology of clades and species. Annu Rev Ecol Syst 33: 25-42, 2002.
140. Olivera BM and Cruz LJ. Conotoxins, in retrospect. Toxicon 39: 7-14, 2001.
141. Olivera BM, Cruz LJ, De Santos V, Lecheminant G, Griffin D, Zeikus R, McIntosh JM, Galyean R, Varga J, Gray WR, and Rivier J. Neuronal Ca channel antagonists. Discrimination between Ca channel subtypes using ω-conotoxin from Conus magus venom. Biochemistry 26: 2086-2090, 1987.
142. Olivera BM, Cruz LJ, and Yoskikami D. Effects of Conus peptides on the behavior of mice. Curr Opin Neurobiol 9: 772-777, 1999.
143. Olivera BM, Gray WR, Zeikus R, McIntosh JM, Varga J, Rivier J, De Santos V, and Cruz LJ. Peptide neurotoxins from fish-hunting cone snails. Science 230: 1338-1343, 1985.
144. Olivera BM, Imperial JS, and Bulaj G. Cone snails and conotoxins: evolving sophisticated neuropharmacology. In: Perspectives in Molecular Toxinology, edited by Menez A. West Sussex, UK: Wiley, 2002.
145. Olivera BM, McIntosh JM, Clark C, Middlemas D, Gray WR, and Cruz LJ. A sleep-inducing peptide from Conus geographus venom. Toxicon 23: 277-282, 1985.
146. Olivera BM, McIntosh JM, Cruz LJ, Luque FA, and Gray WR. Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry 23: 5087-5090, 1984.
147. Olivera BM, Miljanich G, Ramachandran J, and Adams ME. Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-agatoxins. Annu Rev Biochem 63: 823-867, 1994.
148. Olivera BM, Rivier J, Clark C, Ramilo CA, Corpuz GP, Abogadie FC, Mena EE, Woodward SR, Hillyard DR, and Cruz LJ. Diversity of Conus neuropeptides. Science 249: 257-263, 1990.
149. Olivera BM, Walker C, Cartier GE, Hooper D, Santos AD, Schoenfeld R, Shetty R, Watkins M, Bandyopadbyay P, and Hillyard DR. Speciation of cone snails and interspecific hyperdivergence of their venom peptides. Potential evolutionary significance of introns. Ann NY Acad Sci 870: 223-237, 1999.
150. Quiram PA, Jones JJ, and Sine SM. Pairwise interactions between neuronal α7 acetylcholine receptors and α-conotoxin ImI. J Biol Chem 274: 19517-19524, 1999.
151. Quiram PA, McIntosh JM, and Sine SM. Pairwise interactions between neuronal α7 acetylcholine receptors and α-conotoxin PnIB. J Biol Chem 275: 4889-4896, 2000.
152. Quiram PA and Sine SM. Identification of residues in the neuronal α7 acetylcholine receptor that confer selectivity for conotoxin ImI. J Biol Chem 273: 11001-11006, 1998.
153. Quiram PA and Sine SM. Structural elements in α-conotoxin ImI essential for binding to neuronal α7 receptors. J Biol Chem 273: 11007-11011, 1998.
154. Rigby AC, Baleja JD, Furie BC, and Furie B. Three-dimensional structure of a γ-carboxyglutamic acid-containing conotoxin, conantokin-G, from the marine snail Conus geographus. The metal-free conformer. Biochemistry 36: 6906-6914, 1997.
155. 2+ influx. Proc Natl Acad Sci USA 96: 5758-5763, 1999.
156. Röckel D, Korn W, and Kohn AJ. Manual of the Living Conidae. Wiesbaden, Germany: Verlag Christa Hemmen, 1995.
157. Rumphius GE. D'Amboinsche Rariteikamer. Amsterdam: Fr. Halma, 1705.
158. Safo P, Rosenbaum T, Shcherbatko A, Choi D, Han E, Toledo-Aral J, Olivera BM, Brehm P, and Mandel G. Distinction among neuronal subtypes of voltage-activated sodium channels by μ-conotoxin PIIIA. J Neurosci 20: 76-80, 2000.
159. Salgado VL, Yeh JZ, and Narahashi T. Use and voltage-dependent block of the sodium channel by saxotoxin. In: Tetrodotoxin, Saxitoxin and the Molecular Biology of the Sodium Channel, edited by Kao CY and Levinson SR. New York: NY Acad. Sci., 1986, p. 84-95.
160. Satin J, Kyle JW, Fan Z, Rogart R, Fozzard HA, and Makielski JC. Post-repolarization block of cloned sodium-channels by saxitoxin: - the contribution of pore region amino acids. Biophys J 66: 1353-1363, 1994.
161. Sato S, Nakamura H, Ohizumi Y, Kobayashi J, and Hirata Y. The amino acid sequences of homologous hydroxyproline containing myotoxins from the marine snail Conus geographus venom. FEBS Lett 155: 277-280, 1983.
162. Savarin P, Guenneugues M, Gilquin B, Lamthanh H, Gasparini S, Zinn-Justin S, and Menez A. Three-dimensional structure of κ-conotoxin PVIIA, a novel potassium channel-blocking toxin for cone snails. Biochemistry 37: 5407-5416, 1998.
163. Schreiber G and Fersht AR. Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. J Mol Biol 248: 478-486, 1995.
164. Sharpe IA, Gehrmann J, Loughnan ML, Thomas L, Adams DA, Atkins A, Palant E, Craik DJ, Adams DJ, Alewood PF, and Lewis RJ. Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter. Nat Neurosci 4: 902-907, 2001.
165. Shon K, Grilley M, Jacobsen R, Cartier GE, Hopkins C, Gray WR, Watkins M, Hillyard DR, Rivier J, Torres J, Yoshikami D, and Olivera BM. A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from Conus purpurascens venom. Biochemistry 36: 9581-9587, 1997.
166. Shon K, Grilley MM, Marsh M, Yoshikami D, Hall AR, Kurz B, Gray WR, Imperial JS, Hillyard DR, and Olivera BM. Purification, characterization and cloning of the lockjaw peptide from Conus purpurascens venom. Biochemistry 34: 4913-4918, 1995.
167. Shon K, Hasson A, Spira ME, Cruz LJ, Gray WR, and Olivera BM. δ-Conotoxin GmVIA, a novel peptide from the venom of Conus gloriamaris. Biochemistry 33: 11420-11425, 1994.
168. Shon K, Olivera BM, Watkins M, Jacobsen RB, Gray WR, Floresca CZ, Cruz LJ, Hillyard DR, Bring A, Terlau H, and Yoshikami D. μ-Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes. J Neurosci 18: 4473-4481, 1998.
169. + channel. J Biol Chem 273: 33-38, 1998.
170. Sine SM, Kreienkamp HJ, Bren N, Maeda R, and Taylor P. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of α-conotoxin MI selectivity. Neuron 15: 205-211, 1995.
171. Skjaebaek N, Nielsen KJ, Lewis RJ, Alewood P, and Craik DJ. Determination of the solution structures of conantokin-G and conantokin-T by CD and NMR spectroscopy. J Biol Chem 272: 2291-2299, 1997.
172. Skolnick P, Boje K, Miller R, Pennington M, and Maccecchini ML. Noncompetitive inhibition of N-methyl-D-aspartate by conantokin-G: evidence for an allosteric interaction at polyamine sites. J Neurochem 59: 1516-1521, 1992.
173. Smith MT, Cabot PJ, Ross FB, Robertson AD, and Lewis RJ. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 96: 119-127, 2002.
174. Stanley TB, Stafford DW, Olivera BM, and Bandyopadhyay PK. Identification of a vitamin K-dependent carboxylase in the venom duct of a Conus snail. FEBS Lett 407: 85-88, 1997.
175. Stephan MM, Potts JF, and Agnew WS. The microl skeletal muscle sodium channel: mutation E403Q eliminates sensitivity to tetrodotoxin but not to μ-conotoxins GIIIA and GIIIB. J Membr Biol 137: 1-8, 1994.
176. Sugiyama N, Marchot P, Kawanishi C, Osaka H, Molles B, Sine SM, and Taylor P. Residues at the subunit interfaces of the nicotinic acetylcholine receptor that contribute to α-conotoxin MI binding. Mol Pharmacol 53: 787-794, 1998.
177. Tavazoie SF, Tavazoie MF, McIntosh JM, Olivera BM, and Yoshikami D. Differential block of nicotinic synapses on B vs. C neurones in sympathetic ganglia of frog by α-conotoxins MII and ImI. Br J Pharmacol 120: 995-1000, 1997.
178. Taylor JD and Morris NJ. Relationships of Neogastropoda. Malacological Rev Suppl 4: 167-179, 1988.
179. + channels by κ-contoxin PVIIA is state dependent. J Gen Physiol 114: 125-140, 1999.
180. Terlau H, Shon K, Grilley M, Stocker M, Stühmer W, and Olivera BM. Strategy for rapid immobilization of prey by a fish-hunting cone snail. Nature 381: 148-151, 1996.
181. Terlau H, Stocker M, Shon KJ, McIntosh JM, and Olivera BM. Mo-Conotoxin MrVIA inhibits mammalian sodium channels but not through Site I. J Neurosci 76: 1423-1429, 1996.
182. Van Wagoner RM and Ireland CM. An improved solution structure for ψ-contoxoin PIIIE. Biochemistry 42: 6347-6352, 2003.
183. Van Wagoner RM, Jacobsen RB, Olivera BM, and Ireland CM. Characterization and three-dimensional structure determination of ψ-conotoxin PIIIF, a novel noncompetitive antagonist of nicotinic acetylcholine receptors. Biochemistry 42: 6353-6362, 2003.
184. Walker C, Steel D, Jacobsen RB, Lirazan MB, Cruz LJ, Hooper D, Shetty R, Delacruz RC, Nielsen JS, Zhou L, Bandyopadhyay P, Craig A, and Olivera BM. The T-superfamily of conotoxins. J Biol Chem 274: 30664-30671, 1999.
185. Warder SE, Chen Z, Zhu Y, Prorok M, Castellino FJ, and Ni F. The NMR solution structure of the NMDA receptor antagonist, conantokin-T, in the absence of divalent metal ions. FEBS Lett 411: 19-26, 1997.
186. West PJ, Bulaj G, Garrett JE, Olivera BM, and Yoshikami D. μ-Conotoxin SmIIIA, a potent inhibitor of TTX-resistant sodium channels in amphibian sympathetic and sensory neurons. Biochemistry 41: 15388-15393, 2002.
187. White HS, McCabe RT, Abogadie F, Torres J, Rivier JE, Paarmann I, Hollmann M, Olivera BM, and Cruz LJ. Conantokin-R, a subtype-selective NMDA receptor antagonist and potent anticonvulsant peptide. Soc Neurosci Abstr 23: 2164, 1997.
188. White HS, McCabe RT, Armstrong H, Donevan S, Cruz LJ, Abogadie FC, Torres J, Rivier JE, Paarman I, Hollmann M, and Olivera BM. In vitro and in vivo characterization of conantokin-R, a selective NMDA antagonist isolated from the venom of the fish-hunting snail Conus radiatus. J Pharmacol Exp Ther 292: 425-432, 2000.
189. Whiteaker P, Peterson CG, Xu W, McIntosh JM, Paylor R, Beaudet AC, Collins AC, and Marks MJ. The role of the a3 subunit in neuronal nicotinic binding populations. J Neurosci 22: 2522-2529, 2002.
190. Williams AJ, Dave Phillips JB, Lin Y Jr, McCabe RT, and Tortella FC. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J Pharmacol Exp Ther 294: 378-386, 2000.
191. Williams AJ, Ling G, McCabe RT, and Tortella FC. Intrathecal CGX-1007 is neuroprotective in a rat model of focal cerebral ischemia. Neuroreport 13: 821-824, 2002.
192. Wittekindt B, Malany S, Schemm R, Otvos L, Maccecchini ML, Laube B, and Betz H. Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as a major site of conantokin-G inhibition. Neuropharmacology 41: 753-761, 2001.
193. Woodward SR, Cruz LJ, Olivera BM, and Hillyard DR. Constant and hypervariable regions in conotoxin propeptides. EMBO J 1: 1015-1020, 1990.
194. Yoshiba, S. An estimation of the most dangerous species of cone shell. Conus geographus venoms lethal dose to humans. Jpn J Hyg 39: 565-572, 1984.
195. + channel-Fab complex at 2 0 Aτ resolution. Nature 414: 43-48, 2001.
196. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, and Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22: 8785-8789, 2002.